Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
SEC CIK 1903360 · EDGAR
Most active insiders at AVLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SR ONE CAPITAL MANAGEMENT, LLC | 10% | $10.00M | — |
| 2 | Novo Holdings A/S | 10% | $10.00M | — |
| 3 | Carroll Jill | Dir | $5.00M | — |
| 4 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% | — | — |
| 5 | FMR LLC | 10%, See Remark 1 | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-01 18:26 | 2026-05-01 | AVLN | Avalyn Pharma Inc. | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% | C - Cnv Deriv | — | +1.28M | 1.28M | New | — |
| D | 2024-10-15 | 2024-10-15 | UPB | Upstream Bio, Inc. | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% | C - Cnv Deriv | — | +894.7K | 894.7K | New | — |
| DM | 2024-09-17 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% | C - Cnv Deriv | — | +1.79M | 1.79M | New | — |
Purchase Sale Sale after option exercise All abbreviations